U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 349

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr10:50740989
GRCh38:
Chr10:49532943
ERCC6, ERCC6-PGBD3H8fsDE SANCTIS-CACCHIONE SYNDROME, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Pathogenic
(Feb 24, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr10:50678747
GRCh38:
Chr10:49470701
ERCC6R1087*not provided, Cockayne syndrome type 2Pathogenic/Likely pathogenic
(Nov 17, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr10:50681596
GRCh38:
Chr10:49473550
ERCC6K879fsCockayne syndrome type 2Likely pathogenic
(Jan 8, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr10:50680464-50680465
GRCh38:
Chr10:49472418-49472419
ERCC6, LOC126860933R961fsCockayne syndrome type 2Likely pathogenic
(Jan 2, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr10:50684335-50684336
GRCh38:
Chr10:49476289-49476290
ERCC6D770fsCockayne syndrome type 2Likely pathogenic
(Jan 2, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr10:50690767-50690768
GRCh38:
Chr10:49482721-49482722
ERCC6T712fsCockayne syndrome type 2Likely pathogenic
(Jan 2, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr10:50678324
GRCh38:
Chr10:49470278
ERCC6K1228*Cockayne syndrome type 2Likely pathogenic
(Dec 31, 2021)
criteria provided, single submitter
8.
GRCh37:
Chr10:50713988-50713989
GRCh38:
Chr10:49505942-49505943
ERCC6S489fsCockayne syndrome type 2Likely pathogenic
(Dec 31, 2021)
criteria provided, single submitter
9.
GRCh37:
Chr10:50680988
GRCh38:
Chr10:49472942
ERCC6, LOC126860933Y932*Cockayne syndrome type 2Likely pathogenic
(Dec 29, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr10:50690867
GRCh38:
Chr10:49482821
ERCC6Q679*Cockayne syndrome type 2Likely pathogenic
(Dec 29, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr10:50732302
GRCh38:
Chr10:49524256
ERCC6, ERCC6-PGBD3, PGBD3E392*Cockayne syndrome type 2Likely pathogenic
(Dec 17, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr10:50732160-50732169
GRCh38:
Chr10:49524114-49524123
ERCC6, ERCC6-PGBD3, PGBD3A436fsCockayne syndrome type 2Likely pathogenic
(Dec 17, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr10:50678328-50678329
GRCh38:
Chr10:49470282-49470283
ERCC6V1226fsCockayne syndrome type 2Likely pathogenic
(Dec 17, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr10:50691470
GRCh38:
Chr10:49483424
ERCC6Y638*Cockayne syndrome type 2Likely pathogenic
(Dec 16, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr10:50691479
GRCh38:
Chr10:49483433
ERCC6S636fsCockayne syndrome type 2Likely pathogenic
(Dec 16, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr10:50678382-50678383
GRCh38:
Chr10:49470336-49470337
ERCC6S1209fsCockayne syndrome type 2Likely pathogenic
(May 20, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr10:50732261-50732262
GRCh38:
Chr10:49524215-49524216
ERCC6, ERCC6-PGBD3, PGBD3K405fsCockayne syndrome type 2Likely pathogenic
(May 15, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr10:50732436
GRCh38:
Chr10:49524390
ERCC6-PGBD3, ERCC6G347fsnot provided, Cockayne syndrome type 2Pathogenic/Likely pathogenic
(May 19, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr10:50679088-50679089
GRCh38:
Chr10:49471042-49471043
ERCC6L1001fsCockayne syndrome type 2Likely pathogenic
(Dec 8, 2021)
criteria provided, single submitter
20.
GRCh37:
Chr10:50701169
GRCh38:
Chr10:49493123
ERCC6H605fsCockayne syndrome type 2Likely pathogenic
(Apr 5, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr10:50678407-50678408
GRCh38:
Chr10:49470361-49470362
ERCC6L1200fsCockayne syndrome type 2Likely pathogenic
(Dec 7, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr10:50738855
GRCh38:
Chr10:49530809
ERCC6, ERCC6-PGBD3K152*Cockayne syndrome type 2Likely pathogenic
(Apr 1, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr10:50732263
GRCh38:
Chr10:49524217
PGBD3, ERCC6, ERCC6-PGBD3K405*Cockayne syndrome type 2Likely pathogenic
(Mar 31, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr10:50690796
GRCh38:
Chr10:49482750
ERCC6F703fsCockayne syndrome type 2Likely pathogenic
(Mar 15, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr10:50678771-50678772
GRCh38:
Chr10:49470725-49470726
ERCC6E1079fsCockayne syndrome type 2Likely pathogenic
(Mar 15, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr10:50732322
GRCh38:
Chr10:49524276
ERCC6, ERCC6-PGBD3, PGBD3D385fsCockayne syndrome type 2Likely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr10:50738846
GRCh38:
Chr10:49530800
ERCC6, ERCC6-PGBD3E155*Cockayne syndrome type 2Likely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr10:50732701
GRCh38:
Chr10:49524655
ERCC6, ERCC6-PGBD3K259*Cockayne syndrome type 2Likely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr10:50732134
GRCh38:
Chr10:49524088
ERCC6, ERCC6-PGBD3, PGBD3K448*Cockayne syndrome type 2Likely pathogenic
(Mar 3, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr10:50678237-50678238
GRCh38:
Chr10:49470191-49470192
ERCC6K1258fsCockayne syndrome type 2Likely pathogenic
(Mar 3, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr10:50678434-50678435
GRCh38:
Chr10:49470388-49470389
ERCC6A1191fsCockayne syndrome type 2Likely pathogenic
(Mar 3, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr10:50690736
GRCh38:
Chr10:49482690
ERCC6Q723fsCockayne syndrome type 2Likely pathogenic
(Mar 2, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr10:50701224-50701225
GRCh38:
Chr10:49493178-49493179
ERCC6T587fsCockayne syndrome type 2Likely pathogenic
(Feb 28, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr10:50678500-50678501
GRCh38:
Chr10:49470454-49470455
ERCC6W1169fsCockayne syndrome type 2Likely pathogenic
(Feb 27, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr10:50736496
GRCh38:
Chr10:49528450
ERCC6, ERCC6-PGBD3E207*Cockayne syndrome type 2Likely pathogenic
(Feb 25, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr10:50732263-50732264
GRCh38:
Chr10:49524217-49524218
ERCC6, ERCC6-PGBD3, PGBD3K405fsCockayne syndrome type 2Likely pathogenic
(Feb 25, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr10:50678516-50678517
GRCh38:
Chr10:49470470-49470471
ERCC6Q1164fsCockayne syndrome type 2Likely pathogenic
(Feb 17, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr10:50691458
GRCh38:
Chr10:49483412
ERCC6Y642*Cockayne syndrome type 2Likely pathogenic
(Feb 5, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr10:50701265
GRCh38:
Chr10:49493219
ERCC6C573*Cockayne syndrome type 2Likely pathogenic
(Feb 2, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr10:50682123
GRCh38:
Chr10:49474077
ERCC6I850fsCockayne syndrome type 2Likely pathogenic
(Jan 27, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr10:50732201-50732202
GRCh38:
Chr10:49524155-49524156
ERCC6, ERCC6-PGBD3, PGBD3D425fsCockayne syndrome type 2Likely pathogenic
(Jan 25, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr10:50691515-50691517
GRCh38:
Chr10:49483469-49483471
ERCC6T623fsCockayne syndrome type 2Likely pathogenic
(Jan 24, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr10:50678684
GRCh38:
Chr10:49470638
ERCC6G1108*Cockayne syndrome type 2Likely pathogenic
(Jan 23, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr10:50682121-50682124
GRCh38:
Chr10:49474075-49474078
ERCC6K849fsCockayne syndrome type 2Likely pathogenic
(Sep 1, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr10:50738766-50738767
GRCh38:
Chr10:49530720-49530721
ERCC6, ERCC6-PGBD3E182fsCockayne syndrome type 2Likely pathogenic
(Sep 1, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr10:50732626
GRCh38:
Chr10:49524580
ERCC6E284*not provided, Cockayne syndrome type 2Pathogenic
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr10:50690865
GRCh38:
Chr10:49482819
ERCC6not provided, Lung cancer, UV-sensitive syndrome 1,
Premature ovarian failure 11, DE SANCTIS-CACCHIONE SYNDROME, Cerebrooculofacioskeletal syndrome 1,
Cockayne syndrome type 2, Age related macular degeneration 5
Conflicting interpretations of pathogenicity
(Sep 9, 2022)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr10:50668466
GRCh38:
Chr10:49460420
ERCC6F1339LCerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME, Age related macular degeneration 5,
Cockayne syndrome type 2, UV-sensitive syndrome 1, Lung cancer,
Premature ovarian failure 11, not provided, not specified
Uncertain significance
(Dec 13, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr10:50681527
GRCh38:
Chr10:49473481
ERCC6N902Snot provided, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2,
UV-sensitive syndrome 1, Age related macular degeneration 5, Premature ovarian failure 11,
Lung cancer, DE SANCTIS-CACCHIONE SYNDROME
Uncertain significance
(Nov 23, 2021)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr10:50686474
GRCh38:
Chr10:49478428
ERCC6I738LCerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2, DE SANCTIS-CACCHIONE SYNDROME,
Lung cancer, UV-sensitive syndrome 1, Age related macular degeneration 5,
Premature ovarian failure 11, Inborn genetic diseases, not provided,
Cockayne syndrome type 2
Conflicting interpretations of pathogenicity
(Mar 6, 2023)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr10:50684307
GRCh38:
Chr10:49476261
ERCC6F779fsCockayne syndrome type 2Likely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr10:50732755
GRCh38:
Chr10:49524709
ERCC6-PGBD3, ERCC6R241Cnot provided, DE SANCTIS-CACCHIONE SYNDROME, Cerebrooculofacioskeletal syndrome 1,
Cockayne syndrome type 2, UV-sensitive syndrome 1, Age related macular degeneration 5,
Premature ovarian failure 11, Lung cancer
Uncertain significance
(Jun 20, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr10:50736463
GRCh38:
Chr10:49528417
ERCC6, ERCC6-PGBD3E218KCockayne syndrome type 2Uncertain significance
(Jun 23, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr10:50684228
GRCh38:
Chr10:49476182
ERCC6UV-sensitive syndrome 1, not provided, Cockayne syndrome type 2,
DE SANCTIS-CACCHIONE SYNDROME, Cerebrooculofacioskeletal syndrome 1
Benign
(Jul 30, 2021)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr10:50701164
GRCh38:
Chr10:49493118
ERCC6K607Mnot provided, Premature ovarian failure 11, Cerebrooculofacioskeletal syndrome 1,
UV-sensitive syndrome 1, Lung cancer, Age related macular degeneration 5,
Cockayne syndrome type 2, DE SANCTIS-CACCHIONE SYNDROME
Uncertain significance
(May 30, 2023)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr10:50732672
GRCh38:
Chr10:49524626
ERCC6, ERCC6-PGBD3DE SANCTIS-CACCHIONE SYNDROME, Age related macular degeneration 5, UV-sensitive syndrome 1,
Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2, Lung cancer,
Premature ovarian failure 11, not provided
Likely benign
(Apr 11, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr10:50690808-50690809
GRCh38:
Chr10:49482762-49482763
ERCC6T699fsCerebrooculofacioskeletal syndrome 1, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2,
Premature ovarian failure 11, DE SANCTIS-CACCHIONE SYNDROME, UV-sensitive syndrome 1,
Age related macular degeneration 5, Lung cancer, not provided
Pathogenic
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr10:50691550
Chr10:50701257
GRCh38:
Chr10:49483504
Chr10:49493211
ERCC6, ERCC6R612*, T576RCerebrooculofacioskeletal syndrome 1Pathogenic
(May 31, 2019)
no assertion criteria provided
59.
GRCh37:
Chr10:50678249
GRCh38:
Chr10:49470203
ERCC6E1253*Cockayne syndrome type 2Likely pathogenic
(Apr 23, 2019)
criteria provided, single submitter
60.
GRCh37:
Chr10:50736541
GRCh38:
Chr10:49528495
ERCC6, ERCC6-PGBD3Q192*not provided, Cockayne syndrome type 2Pathogenic/Likely pathogenic
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr10:50713940
GRCh38:
Chr10:49505894
ERCC6K506*Cockayne syndrome type 2Likely pathogenic
(Jul 6, 2019)
criteria provided, single submitter
62.
GRCh37:
Chr10:50701207
GRCh38:
Chr10:49493161
ERCC6R593*Cockayne syndrome type 2Likely pathogenic
(Dec 28, 2019)
criteria provided, single submitter
63.
GRCh37:
Chr10:50701168
GRCh38:
Chr10:49493122
ERCC6K606*Cockayne syndrome type 2Likely pathogenic
(Feb 5, 2019)
criteria provided, single submitter
64.
GRCh37:
Chr10:50686485
GRCh38:
Chr10:49478439
ERCC6L734*Cockayne syndrome type 2Likely pathogenic
(Dec 6, 2019)
criteria provided, single submitter
65.
GRCh37:
Chr10:50684263
GRCh38:
Chr10:49476217
ERCC6Q794*Cockayne syndrome type 2Likely pathogenic
(Sep 7, 2019)
criteria provided, single submitter
66.
GRCh37:
Chr10:50682167
GRCh38:
Chr10:49474121
ERCC6W835*Cockayne syndrome type 2Likely pathogenic
(Mar 31, 2019)
criteria provided, single submitter
67.
GRCh37:
Chr10:50682128
GRCh38:
Chr10:49474082
ERCC6L848*Cockayne syndrome type 2Likely pathogenic
(Oct 24, 2019)
criteria provided, single submitter
68.
GRCh37:
Chr10:50682105
GRCh38:
Chr10:49474059
ERCC6Q856*Cockayne syndrome type 2Likely pathogenic
(Mar 5, 2020)
criteria provided, single submitter
69.
GRCh37:
Chr10:50680977
GRCh38:
Chr10:49472931
ERCC6, LOC126860933W936*Cockayne syndrome type 2Likely pathogenic
(May 7, 2019)
criteria provided, single submitter
70.
GRCh37:
Chr10:50680500
GRCh38:
Chr10:49472454
ERCC6, LOC126860933W949*Cockayne syndrome type 2Likely pathogenic
(Dec 4, 2019)
criteria provided, single submitter
71.
GRCh37:
Chr10:50679084
GRCh38:
Chr10:49471038
ERCC6E1003*Cockayne syndrome type 2Likely pathogenic
(Dec 15, 2019)
criteria provided, single submitter
72.
GRCh37:
Chr10:50679021
GRCh38:
Chr10:49470975
ERCC6G1024*Cockayne syndrome type 2Likely pathogenic
(Dec 23, 2019)
criteria provided, single submitter
73.
GRCh37:
Chr10:50678909
GRCh38:
Chr10:49470863
ERCC6K1033*Cockayne syndrome type 2Likely pathogenic
(Dec 27, 2019)
criteria provided, single submitter
74.
GRCh37:
Chr10:50678651
GRCh38:
Chr10:49470605
ERCC6E1119*Cockayne syndrome type 2Likely pathogenic
(Jun 28, 2019)
criteria provided, single submitter
75.
GRCh37:
Chr10:50678558
GRCh38:
Chr10:49470512
ERCC6K1150*Cockayne syndrome type 2Likely pathogenic
(May 31, 2019)
criteria provided, single submitter
76.
GRCh37:
Chr10:50678541
GRCh38:
Chr10:49470495
ERCC6Y1155*Cockayne syndrome type 2Likely pathogenic
(Mar 3, 2020)
criteria provided, single submitter
77.
GRCh37:
Chr10:50678462
GRCh38:
Chr10:49470416
ERCC6K1182*Cockayne syndrome type 2Likely pathogenic
(May 1, 2019)
criteria provided, single submitter
78.
GRCh37:
Chr10:50678432
GRCh38:
Chr10:49470386
ERCC6E1192*Cockayne syndrome type 2Likely pathogenic
(Apr 27, 2019)
criteria provided, single submitter
79.
GRCh37:
Chr10:50678369
GRCh38:
Chr10:49470323
ERCC6R1213*Cockayne syndrome type 2Likely pathogenic
(Oct 24, 2019)
criteria provided, single submitter
80.
GRCh37:
Chr10:50678351
GRCh38:
Chr10:49470305
ERCC6G1219*Cockayne syndrome type 2Likely pathogenic
(Aug 5, 2019)
criteria provided, single submitter
81.
GRCh37:
Chr10:50738765
GRCh38:
Chr10:49530719
ERCC6-PGBD3, ERCC6Cockayne syndrome type 2Likely pathogeniccriteria provided, single submitter
82.
GRCh37:
Chr10:50701310
GRCh38:
Chr10:49493264
ERCC6not provided, Age related macular degeneration 5, Cockayne syndrome type 2,
Cerebrooculofacioskeletal syndrome 1
Conflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
83.
GRCh37:
Chr10:50669480
GRCh38:
Chr10:49461434
ERCC6R1301Cnot provided, Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1,
Cockayne syndrome type 2
Uncertain significance
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr10:50666615
GRCh38:
Chr10:49458569
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
85.
GRCh37:
Chr10:50664321
GRCh38:
Chr10:49456275
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Mar 30, 2018)
criteria provided, single submitter
86.
GRCh37:
Chr10:50664259
GRCh38:
Chr10:49456213
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
87.
GRCh37:
Chr10:50663505
GRCh38:
Chr10:49455459
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr10:50663495
GRCh38:
Chr10:49455449
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
89.
GRCh37:
Chr10:50732518
GRCh38:
Chr10:49524472
ERCC6, ERCC6-PGBD3V320LAge related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr10:50662653
GRCh38:
Chr10:49454607
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Likely benign
(Jan 13, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr10:50732239
GRCh38:
Chr10:49524193
ERCC6, ERCC6-PGBD3, PGBD3R413Wnot specified, not provided, Age related macular degeneration 5,
Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr10:50666048
GRCh38:
Chr10:49458002
ERCC6Cerebrooculofacioskeletal syndrome 1, Age related macular degeneration 5, Cockayne syndrome type 2
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
93.
GRCh37:
Chr10:50664830
GRCh38:
Chr10:49456784
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
94.
GRCh37:
Chr10:50664199
GRCh38:
Chr10:49456153
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
95.
GRCh37:
Chr10:50664181
GRCh38:
Chr10:49456135
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
96.
GRCh37:
Chr10:50738895
GRCh38:
Chr10:49530849
ERCC6, ERCC6-PGBD3not provided, Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1,
Cockayne syndrome type 2
Conflicting interpretations of pathogenicity
(Sep 24, 2022)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr10:50738893
GRCh38:
Chr10:49530847
ERCC6, ERCC6-PGBD3not provided, Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1,
Cockayne syndrome type 2
Conflicting interpretations of pathogenicity
(Sep 10, 2020)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr10:50738878
GRCh38:
Chr10:49530832
ERCC6T144Mnot provided, Age related macular degeneration 5, Cockayne syndrome type 2,
Cerebrooculofacioskeletal syndrome 1
Conflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr10:50663466
GRCh38:
Chr10:49455420
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Benign
(Jan 12, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr10:50663177
GRCh38:
Chr10:49455131
ERCC6Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination